1. Home
  2. WAL vs TECH Comparison

WAL vs TECH Comparison

Compare WAL & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WAL
  • TECH
  • Stock Information
  • Founded
  • WAL 1994
  • TECH 1976
  • Country
  • WAL United States
  • TECH United States
  • Employees
  • WAL N/A
  • TECH N/A
  • Industry
  • WAL Major Banks
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • WAL Finance
  • TECH Health Care
  • Exchange
  • WAL Nasdaq
  • TECH Nasdaq
  • Market Cap
  • WAL 7.8B
  • TECH 7.8B
  • IPO Year
  • WAL 2005
  • TECH 1989
  • Fundamental
  • Price
  • WAL $78.18
  • TECH $49.15
  • Analyst Decision
  • WAL Strong Buy
  • TECH Buy
  • Analyst Count
  • WAL 15
  • TECH 10
  • Target Price
  • WAL $95.13
  • TECH $73.44
  • AVG Volume (30 Days)
  • WAL 1.0M
  • TECH 2.3M
  • Earning Date
  • WAL 04-21-2025
  • TECH 05-07-2025
  • Dividend Yield
  • WAL 1.93%
  • TECH 0.65%
  • EPS Growth
  • WAL 6.13
  • TECH N/A
  • EPS
  • WAL 7.28
  • TECH 0.83
  • Revenue
  • WAL $3,049,400,000.00
  • TECH $1,208,770,000.00
  • Revenue This Year
  • WAL $13.26
  • TECH $8.19
  • Revenue Next Year
  • WAL $9.87
  • TECH $8.61
  • P/E Ratio
  • WAL $10.85
  • TECH $59.07
  • Revenue Growth
  • WAL 11.37
  • TECH 4.72
  • 52 Week Low
  • WAL $56.70
  • TECH $46.44
  • 52 Week High
  • WAL $98.10
  • TECH $85.57
  • Technical
  • Relative Strength Index (RSI)
  • WAL 61.58
  • TECH 44.74
  • Support Level
  • WAL $70.45
  • TECH $46.35
  • Resistance Level
  • WAL $80.47
  • TECH $54.40
  • Average True Range (ATR)
  • WAL 2.11
  • TECH 2.17
  • MACD
  • WAL 1.07
  • TECH 0.27
  • Stochastic Oscillator
  • WAL 78.52
  • TECH 34.78

About WAL Western Alliance Bancorporation (DE)

Western Alliance Bancorporation is a Las Vegas-based holding company with regional banks operating in Nevada, Arizona, and California. The bank offers retail banking services and focuses on mortgages for retail customers and commercial loans. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Share on Social Networks: